{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:29:58Z","timestamp":1767914998222,"version":"3.49.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/etm.2014.2093","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T13:06:57Z","timestamp":1417093617000},"page":"626-630","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis"],"prefix":"10.3892","volume":"9","author":[{"given":"GUANG","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LU","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOFAN","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIUYU","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJIE","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"JU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIPING","family":"ZOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"key20180108130113_b1-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","article-title":"Tuberous sclerosis complex: tumors and tumorigenesis","volume":"50","author":"Borkowska","year":"2011","journal-title":"Int J Dermatol"},{"key":"key20180108130113_b2-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"key20180108130113_b3-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108130113_b4-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.acvd.2012.01.009","article-title":"Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature","volume":"105","author":"Benyounes","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"key20180108130113_b5-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ajmg.a.33320","article-title":"Absence of signs of systemic involvement in four patients with bilateral multiple facial angiofibromas","volume":"152A","author":"Hunter","year":"2010","journal-title":"Am J Med Genet A"},{"key":"key20180108130113_b6-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00381-012-1962-y","article-title":"Subependymal giant cell astrocytoma associated with tuberous sclerosis presenting with intratumoral bleeding. Case report and review of literature","volume":"29","author":"Sterman","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"key20180108130113_b7-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0032-1325159","article-title":"Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment","volume":"33","author":"Meraj","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"key20180108130113_b8-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","article-title":"Evolving neurobiology of tuberous sclerosis complex","volume":"125","author":"Crino","year":"2013","journal-title":"Acta Neuropathol"},{"key":"key20180108130113_b9-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11910-012-0269-4","article-title":"Molecular therapies for tuberous sclerosis and neurofibromatosis","volume":"12","author":"Franz","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key20180108130113_b10-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108130113_b11-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157015912804499537","article-title":"mTOR inhibitors in tuberous sclerosis complex","volume":"10","author":"Curatolo","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"key20180108130113_b12-etm-09-02-0626","first-page":"211","article-title":"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex","volume":"7","author":"Franz","year":"2013","journal-title":"Biologics"},{"key":"key20180108130113_b13-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/pbc.22401","article-title":"Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex","volume":"54","author":"Pressey","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108130113_b14-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/pbc.22298","article-title":"Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors","volume":"54","author":"Lam","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108130113_b15-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"key20180108130113_b16-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"key20180108130113_b17-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3171\/2010.7.PEDS10221","article-title":"Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex","volume":"6","author":"Birca","year":"2010","journal-title":"J Neurosurg Pediatr"},{"key":"key20180108130113_b18-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s11255-012-0292-z","article-title":"Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis","volume":"44","author":"Staehler","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"key20180108130113_b19-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pediatrneurol.2010.01.016","article-title":"Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus","volume":"42","author":"Sparagana","year":"2010","journal-title":"Pediatr Neurol"},{"key":"key20180108130113_b20-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"key20180108130113_b21-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key20180108130113_b22-etm-09-02-0626","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.10","author":"Higgins","year":"2011"},{"key":"key20180108130113_b23-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key20180108130113_b24-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0272989X05282643","article-title":"The interpretation of random-effects meta-analysis in decision models","volume":"25","author":"Ades","year":"2005","journal-title":"Med Decis Making"},{"key":"key20180108130113_b25-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"key20180108130113_b26-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.2011.00837.x","article-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients","volume":"53","author":"Foster","year":"2012","journal-title":"Australas J Dermatol"},{"key":"key20180108130113_b27-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma","volume":"26","author":"Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20180108130113_b28-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20180108130113_b29-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2012.05.015","article-title":"From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches","volume":"68","author":"Ehninger","year":"2013","journal-title":"Neuropharmacology"},{"key":"key20180108130113_b30-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.febslet.2011.02.001","article-title":"TSC1\/TSC2 signaling in the CNS","volume":"585","author":"Han","year":"2011","journal-title":"FEBS Lett"},{"key":"key20180108130113_b31-etm-09-02-0626","first-page":"17","article-title":"Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity","volume":"229","author":"Yang","year":"2014","journal-title":"J Cell Physiol"},{"key":"key20180108130113_b32-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1541-7786.MCR-12-0605","article-title":"Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis","volume":"11","author":"Guo","year":"2013","journal-title":"Mol Cancer Res"},{"key":"key20180108130113_b33-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2012.11.003","article-title":"Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex","volume":"67","author":"Cambiaghi","year":"2013","journal-title":"Neuropharmacology"},{"key":"key20180108130113_b34-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4161\/cc.11.3.19096","article-title":"mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors","volume":"11","author":"Zhang","year":"2012","journal-title":"Cell Cycle"},{"key":"key20180108130113_b35-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key20180108130113_b36-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2004-09-3540","article-title":"Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF","volume":"105","author":"Guba","year":"2005","journal-title":"Blood"},{"key":"key20180108130113_b37-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"897025","DOI":"10.1155\/2013\/897025","article-title":"Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis","volume":"2013","author":"Frost","year":"2013","journal-title":"J Oncol"},{"key":"key20180108130113_b38-etm-09-02-0626","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2009.12.018","article-title":"Metabolic control of puberty onset: new players, new mechanisms","volume":"324","author":"Roa","year":"2010","journal-title":"Mol Cell Endocrinol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.2093\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:53:23Z","timestamp":1717584803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.2093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,27]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/etm.2014.2093"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.2093","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}